Celgene chief Bob Hugin ponders a new era for neurodegeneration R&D

John Carroll

SAN FRANCISCO–During a luncheon meeting with reporters at a hotel near a bustling Union Square, CEO Bob –soon to be the executive chairman as Mark Alles moves into the CEO suite–was asked where he was interested in taking the company.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS